Sponsor pipeline

GT Medical Technologies, Inc. clinical trial pipeline

4 active trials 2 recruiting 2 Phase 3 1 disease areas 1 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Phase 3		2
Phase 4		1

Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

NCT ID	Title	Condition	Status	Updated
Phase 4
NCT05342883	GammaTile and Stupp in Newly Diagnosed GBM	Glioblastoma	Active, Not Recruiting	2025-09-05
Phase 3
NCT07195591	Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care	Glioblastoma	Recruiting	2026-10-05
NCT04365374	Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and…	Brain Metastases	Active, Not Recruiting	2025-10-07
Not specified
NCT04427384	Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)	Brain Tumor, Recurrent	Recruiting	2026-07-22

Get alerts when GT Medical Technologies, Inc.'s trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.